Vycor Medical (VYCO) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.48% |
| Dec 31, 2025 | 53.84% |
| Sep 30, 2025 | 15.05% |
| Jun 30, 2025 | 24.96% |
| Mar 31, 2025 | 4.91% |
| Dec 31, 2024 | -58.54% |
| Sep 30, 2024 | -11.77% |
| Jun 30, 2024 | 55.13% |
| Mar 31, 2024 | 16.05% |
| Dec 31, 2023 | -26.58% |
| Sep 30, 2023 | 16.23% |
| Jun 30, 2023 | 16.37% |
| Mar 31, 2023 | 16.76% |
| Dec 31, 2022 | 28.32% |
| Sep 30, 2022 | 5.47% |
| Jun 30, 2022 | -33.18% |
| Mar 31, 2022 | 20.16% |
| Dec 31, 2021 | 17.95% |
| Sep 30, 2021 | -86.14% |
| Jun 30, 2021 | 19.85% |
| Mar 31, 2021 | 29.78% |
| Dec 31, 2020 | 42.39% |
| Sep 30, 2020 | 12.66% |
| Jun 30, 2020 | 29.19% |
| Mar 31, 2020 | 41.43% |
| Sep 30, 2019 | 15.55% |
| Jun 30, 2019 | 54.57% |
| Mar 31, 2019 | 56.49% |
| Dec 31, 2018 | 17.58% |
| Sep 30, 2018 | 18.94% |
| Jun 30, 2018 | 18.17% |
| Mar 31, 2018 | 11.32% |
| Dec 31, 2017 | 10.97% |
| Sep 30, 2017 | 21.56% |
| Jun 30, 2017 | 54.06% |
| Mar 31, 2017 | 8.82% |
| Dec 31, 2016 | 31.84% |
| Sep 30, 2016 | 69.45% |
| Jun 30, 2016 | 26.05% |
| Mar 31, 2016 | 18.67% |
| Dec 31, 2015 | 23.12% |
| Sep 30, 2015 | 0.65% |